- Home
- ARVN vs SHBI Comparison
ARVN vs SHBI Comparison
Compare ARVN & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- SHBI
- Stock Information
- Founded
- ARVN 2015
- SHBI 1876
- Country
- ARVN United States
- SHBI United States
- Employees
- ARVN N/A
- SHBI N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- SHBI Major Banks
- Sector
- ARVN Health Care
- SHBI Finance
- Exchange
- ARVN Nasdaq
- SHBI Nasdaq
- Market Cap
- ARVN 456.2M
- SHBI 415.6M
- IPO Year
- ARVN 2018
- SHBI N/A
- Fundamental
- Price
- ARVN $7.77
- SHBI $16.34
- Analyst Decision
- ARVN Buy
- SHBI Buy
- Analyst Count
- ARVN 21
- SHBI 2
- Target Price
- ARVN $20.53
- SHBI $20.00
- AVG Volume (30 Days)
- ARVN 2.1M
- SHBI 173.0K
- Earning Date
- ARVN 07-29-2025
- SHBI 07-24-2025
- Dividend Yield
- ARVN N/A
- SHBI 3.03%
- EPS Growth
- ARVN N/A
- SHBI 241.50
- EPS
- ARVN N/A
- SHBI 1.48
- Revenue
- ARVN $426,900,000.00
- SHBI $201,667,000.00
- Revenue This Year
- ARVN $4.26
- SHBI $6.10
- Revenue Next Year
- ARVN N/A
- SHBI $7.16
- P/E Ratio
- ARVN N/A
- SHBI $10.69
- Revenue Growth
- ARVN 498.74
- SHBI 37.93
- 52 Week Low
- ARVN $5.90
- SHBI $11.03
- 52 Week High
- ARVN $34.11
- SHBI $17.61
- Technical
- Relative Strength Index (RSI)
- ARVN 50.16
- SHBI 68.06
- Support Level
- ARVN $7.09
- SHBI $14.35
- Resistance Level
- ARVN $7.89
- SHBI $15.88
- Average True Range (ATR)
- ARVN 0.35
- SHBI 0.33
- MACD
- ARVN 0.00
- SHBI 0.08
- Stochastic Oscillator
- ARVN 38.14
- SHBI 93.79
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About SHBI Shore Bancshares Inc
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in two business segments - community banking and mortgage banking. Community banking is conducted through the Bank and involves delivering a broad range of financial services, including lending and deposit-taking, to individuals and commercial enterprises, it also includes treasury and administrative functions. Mortgage banking is conducted through the Bank's secondary marketing department and involves originating first and second-lien residential mortgages for sale in the secondary market.